Whalesbook Logo

Whalesbook

  • Home
  • About Us
  • Contact Us
  • News

Gold and Silver Prices Decline for Third Consecutive Week Amidst Stronger Dollar and Fed Caution

Commodities

|

Updated on 08 Nov 2025, 01:48 pm

Whalesbook Logo

Reviewed By

Simar Singh | Whalesbook News Team

Short Description:

Gold and silver prices have fallen for the third consecutive week, primarily due to a strengthening US dollar and cautious statements from Federal Reserve officials that dampened investor appetite for safe-haven assets. MCX gold futures closed lower for the week, while silver also saw declines amid concerns about industrial demand and global economic slowdown. Analysts expect prices to remain range-bound until clearer economic cues emerge.
Gold and Silver Prices Decline for Third Consecutive Week Amidst Stronger Dollar and Fed Caution

▶

Detailed Coverage:

Gold and silver prices are experiencing a sustained decline for the third week in a row. This trend is largely attributed to a robust US dollar and cautious commentary from officials at the US Federal Reserve, which has dampened investor enthusiasm for safe-haven assets.

On the Multi Commodity Exchange (MCX) in India, gold futures for December delivery ended the week at Rs 1,21,067 per 10 grams, marking a 0.14% decrease. Globally, Comex gold futures saw a slight increase, settling at $4,009.8 per ounce. Silver futures on MCX also declined by 0.38% to Rs 1,47,728 per kilogram, underperforming gold due to weakening industrial sentiment.

Analysts point to several key drivers. The persistent strength of the US dollar and the Federal Reserve's "wait-and-watch" approach have created uncertainty. Expectations of a potential Federal Reserve rate cut provide some support for gold, but this is counteracted by the stronger dollar and higher Treasury yields. A significant negative factor mentioned is China's decision to reduce its Value Added Tax (VAT) exemption on certain retail gold purchases, which is expected to reduce physical demand in Asia. The prolonged US government shutdown has also contributed to a "data vacuum," creating further uncertainty.

**Impact** This news directly impacts investors holding gold and silver, commodity traders, and consumers looking to buy precious metals. For India, where gold holds significant cultural and investment importance, these price movements are closely watched. Lower gold prices can benefit consumers but may affect companies involved in gold mining or jewelry retail, depending on their pricing strategies and hedging. Silver's decline, linked to industrial demand, reflects broader economic concerns.

**Impact Rating**: 7/10.

**Difficult Terms Explained**: * **Bullion**: Gold or silver in bulk form, usually with a high degree of purity. * **Safe-haven assets**: Investments that are perceived to retain or increase their value during times of market turbulence or economic uncertainty. * **Multi Commodity Exchange (MCX)**: An Indian commodity derivatives exchange, allowing trading in commodity futures. * **Comex**: A division of the New York Mercantile Exchange (NYMEX) where precious metals futures are traded. * **Futures**: A financial contract obligating the buyer to purchase an asset or the seller to sell the asset at a predetermined future date and price. * **Dollar Index**: A measure of the value of the United States dollar relative to a basket of foreign currencies. * **Treasury yields**: The interest rate at which investors are willing to lend money to the US government for a specific period. * **Federal Reserve**: The central banking system of the United States. * **Rate cut**: A reduction in the central bank's benchmark interest rate. * **Value Added Tax (VAT)**: A consumption tax placed on a product whenever value is added at each stage of the supply chain, from production to the point of sale. * **High-beta behaviour**: Refers to a security or asset that exhibits higher volatility than the overall market. * **ETF outflows**: When investors sell their shares in an Exchange Traded Fund, leading to money leaving the fund. * **Rupee**: The currency of India.


IPO Sector

Capillary Technologies Files for IPO, Plans to Raise Rs 345 Crore Starting November 14

Capillary Technologies Files for IPO, Plans to Raise Rs 345 Crore Starting November 14

India's Primary Market Set for Bumper Week with Multiple IPOs and Listings

India's Primary Market Set for Bumper Week with Multiple IPOs and Listings

Warren Buffett's 70-Year IPO Stance Casts Shadow on Lenskart's Highly Anticipated Debut

Warren Buffett's 70-Year IPO Stance Casts Shadow on Lenskart's Highly Anticipated Debut

Capillary Technologies Files for IPO, Plans to Raise Rs 345 Crore Starting November 14

Capillary Technologies Files for IPO, Plans to Raise Rs 345 Crore Starting November 14

India's Primary Market Set for Bumper Week with Multiple IPOs and Listings

India's Primary Market Set for Bumper Week with Multiple IPOs and Listings

Warren Buffett's 70-Year IPO Stance Casts Shadow on Lenskart's Highly Anticipated Debut

Warren Buffett's 70-Year IPO Stance Casts Shadow on Lenskart's Highly Anticipated Debut


Healthcare/Biotech Sector

India Extends Deadline for ₹5,000 Crore Pharma Innovation Scheme to Boost Global Hub Ambitions

India Extends Deadline for ₹5,000 Crore Pharma Innovation Scheme to Boost Global Hub Ambitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Extends Deadline for ₹5,000 Crore Pharma Innovation Scheme to Boost Global Hub Ambitions

India Extends Deadline for ₹5,000 Crore Pharma Innovation Scheme to Boost Global Hub Ambitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

Poly Medicure Reports 5% Rise in Q2 FY26 Net Profit, Driven by Domestic Growth and Strategic Acquisitions

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

SMS Pharmaceuticals Reports 76.4% Profit Jump on Strong Revenue Growth

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns

India Mandates Stricter Pharma Manufacturing Standards by January Amidst Child Death Concerns